Clinical Trials Browser

Phase 2 × Biliary Tract Carcinoma × Bevacizumab × Clear all

NCT04984980 2023-01-26

Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Carcinoma